115 related articles for article (PubMed ID: 37060774)
21. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
Pease M; Gersey ZC; Ak M; Elakkad A; Kotrotsou A; Zenkin S; Elshafeey N; Mamindla P; Kumar VA; Kumar AJ; Colen RR; Zinn PO
J Neurooncol; 2022 Oct; 160(1):253-263. PubMed ID: 36239836
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
[TBL] [Abstract][Full Text] [Related]
23. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
Beig N; Singh S; Bera K; Prasanna P; Singh G; Chen J; Saeed Bamashmos A; Barnett A; Hunter K; Statsevych V; Hill VB; Varadan V; Madabhushi A; Ahluwalia MS; Tiwari P
Neuro Oncol; 2021 Feb; 23(2):251-263. PubMed ID: 33068415
[TBL] [Abstract][Full Text] [Related]
24. Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19.
Wu Q; Wang S; Li L; Wu Q; Qian W; Hu Y; Li L; Zhou X; Ma H; Li H; Wang M; Qiu X; Zha Y; Tian J
Theranostics; 2020; 10(16):7231-7244. PubMed ID: 32641989
[No Abstract] [Full Text] [Related]
25. Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.
Sun Q; Chen Y; Liang C; Zhao Y; Lv X; Zou Y; Yan K; Zheng H; Liang D; Li ZC
Radiology; 2021 Dec; 301(3):654-663. PubMed ID: 34519578
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
[TBL] [Abstract][Full Text] [Related]
27. A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment.
Jia X; Zhai Y; Song D; Wang Y; Wei S; Yang F; Wei X
Front Oncol; 2022; 12():758622. PubMed ID: 35251957
[TBL] [Abstract][Full Text] [Related]
28. Spatial heterogeneity of edema region uncovers survival-relevant habitat of Glioblastoma.
Yang Y; Han Y; Zhao S; Xiao G; Guo L; Zhang X; Cui G
Eur J Radiol; 2022 Sep; 154():110423. PubMed ID: 35777079
[TBL] [Abstract][Full Text] [Related]
29. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
30. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
[TBL] [Abstract][Full Text] [Related]
31. Time-to-event overall survival prediction in glioblastoma multiforme patients using magnetic resonance imaging radiomics.
Hajianfar G; Haddadi Avval A; Hosseini SA; Nazari M; Oveisi M; Shiri I; Zaidi H
Radiol Med; 2023 Dec; 128(12):1521-1534. PubMed ID: 37751102
[TBL] [Abstract][Full Text] [Related]
32. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
[TBL] [Abstract][Full Text] [Related]
33. Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma.
Pan ZQ; Zhang SJ; Wang XL; Jiao YX; Qiu JJ
Behav Neurol; 2020; 2020():1712604. PubMed ID: 33163122
[TBL] [Abstract][Full Text] [Related]
34. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
35. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R
Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233
[TBL] [Abstract][Full Text] [Related]
37. Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma.
Sasaki T; Kinoshita M; Fujita K; Fukai J; Hayashi N; Uematsu Y; Okita Y; Nonaka M; Moriuchi S; Uda T; Tsuyuguchi N; Arita H; Mori K; Ishibashi K; Takano K; Nishida N; Shofuda T; Yoshioka E; Kanematsu D; Kodama Y; Mano M; Nakao N; Kanemura Y
Sci Rep; 2019 Oct; 9(1):14435. PubMed ID: 31594994
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
39. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
[TBL] [Abstract][Full Text] [Related]
40. Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.
Grossmann P; Narayan V; Chang K; Rahman R; Abrey L; Reardon DA; Schwartz LH; Wen PY; Alexander BM; Huang R; Aerts HJWL
Neuro Oncol; 2017 Nov; 19(12):1688-1697. PubMed ID: 28499022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]